Sector Chart Kinnate Biopharma Inc.

Equities

KNTE

US49705R1059

Delayed Nasdaq 04:00:00 2024-04-02 pm EDT 5-day change 1st Jan Change
2.65 USD -0.38% Intraday chart for Kinnate Biopharma Inc. -.--% +11.81%
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
125M - - - - -
47.96B -
42.45B
41.47B
31.6B -
28.63B